Shares of Silence Therapeutics plc (OTCMKTS:SLNCF – Get Free Report) shot up 12.5% during trading on Monday . The company traded as high as $2.45 and last traded at $2.25. 3,777 shares were traded during trading, an increase of 164% from the average session volume of 1,433 shares. The stock had previously closed at $2.00.
Silence Therapeutics Price Performance
The company’s fifty day simple moving average is $4.48 and its 200 day simple moving average is $5.91.
About Silence Therapeutics
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company's mRNAi GalNAc Oligonucleotide Discovery platform consists of precision engineered product candidates designed to target specific disease-associated genes in the liver.
Featured Stories
- Five stocks we like better than Silence Therapeutics
- 3 Fintech Stocks With Good 2021 Prospects
- Dow Jones: A Relevant Benchmark or a Relic of the Past?
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- 3 Big-Name Stocks Just Announced Big-Time Dividend Increases
- Breakout Stocks: What They Are and How to Identify Them
- Market Overreaction: 2 Stocks to Buy on the Way Down
Receive News & Ratings for Silence Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silence Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
